Bioceres Crop Solutions (BIOX)

Search documents
Bioceres Crop Solutions Corp < > presents at the 5th Annual Best Ideas Growth Virtual Conference Big 5 - slideshow
2021-09-17 17:09
Company Overview - Bioceres Crop Solutions is a fully-integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality[2] - The company has 43 years of experience in developing and commercializing products that enhance crop quality and productivity[3] Financial Performance - Revenues for FY21 reached $1974 million[3], and Adjusted EBITDA reached $483 million[4] - In Q4 2021, total revenue was $822 million, with a gross profit of $324 million representing a 39% gross profit margin[23] - Net debt is (34) million[23] HB4 Technology - HB4 technology shows a +13% impact on soy yields and +195% impact on wheat yields[8] - The total addressable market for HB4 in soy is 20-25 million hectares with a ~25-30% share of the total market, and for wheat, it's 25-30 million hectares with a ~30-35% share of the total market[8] - Regulatory approval for HB4 soy covers over 85% of the global soy market (Argentina, Brazil, Canada, and US)[9] Sustainability and Digital Technologies - The company is focused on scalable sustainability through water & CO2 management, soil conservation, and no-till farming practices[18] - Bioceres utilizes digital technologies for tracking productivity and environmental KPIs, smart contracts, and farm-to-fork traceability[19] Product Portfolio and IP - The company has a diversified product portfolio including adjuvants, crop protection, inoculants & biofertilizers, crop nutrition, and seed and integrated products[29] - Bioceres has a strong IP asset portfolio with 214 patents and applications, and numerous trademarks and plant variety protections[30]
Bioceres Crop Solutions (BIOX) - 2020 Q4 - Annual Report
2020-10-21 20:55
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ¨ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2020 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ OR ¨ SHELL COMPANY REPORT PURS ...
Bioceres Crop Solutions (BIOX) - 2019 Q4 - Annual Report
2019-10-24 19:47
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR o SHELL COMPANY REPORT PURSUANT TO SECTION ...